Bayer CropScience Limited (BOM:506285)
4,502.35
+128.90 (2.95%)
At close: May 26, 2026
Bayer CropScience Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 56,750 | 54,734 | 51,062 | 51,397 | 47,344 |
Other Revenue | 950 | - | - | - | - |
| 57,700 | 54,734 | 51,062 | 51,397 | 47,344 | |
Revenue Growth (YoY) | 5.42% | 7.19% | -0.65% | 8.56% | 11.10% |
Cost of Revenue | 33,775 | 34,142 | 29,256 | 28,305 | 26,771 |
Gross Profit | 23,925 | 20,592 | 21,806 | 23,092 | 20,573 |
Selling, General & Admin | 4,381 | 7,527 | 6,902 | 8,616 | 7,836 |
Other Operating Expenses | 9,857 | 6,149 | 5,117 | 5,211 | 4,589 |
Operating Expenses | 15,178 | 14,525 | 12,759 | 14,622 | 13,070 |
Operating Income | 8,747 | 6,067 | 9,047 | 8,470 | 7,503 |
Interest Expense | -198 | -170 | -196 | -223 | -118 |
Interest & Investment Income | - | 566 | 484 | 340 | 245 |
Currency Exchange Gain (Loss) | - | -2 | -2 | -22 | -2 |
Other Non Operating Income (Expenses) | - | 166 | 148 | 159 | 184 |
EBT Excluding Unusual Items | 8,549 | 6,627 | 9,481 | 8,724 | 7,812 |
Gain (Loss) on Sale of Investments | - | 191 | 148 | 135 | 94 |
Gain (Loss) on Sale of Assets | - | 256 | -24 | 1,043 | 579 |
Asset Writedown | - | - | -191 | -1 | -17 |
Pretax Income | 8,549 | 7,074 | 9,414 | 9,901 | 8,468 |
Income Tax Expense | 1,657 | 1,394 | 2,009 | 2,319 | 2,015 |
Net Income | 6,892 | 5,680 | 7,405 | 7,582 | 6,453 |
Net Income to Common | 6,892 | 5,680 | 7,405 | 7,582 | 6,453 |
Net Income Growth | 21.34% | -23.29% | -2.33% | 17.50% | 30.87% |
Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 |
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 |
Shares Change (YoY) | 0.00% | - | - | - | - |
EPS (Basic) | 153.35 | 126.38 | 164.77 | 168.71 | 143.58 |
EPS (Diluted) | 153.35 | 126.38 | 164.77 | 168.71 | 143.58 |
EPS Growth | 21.34% | -23.29% | -2.33% | 17.50% | 30.87% |
Free Cash Flow | 10,386 | 2,211 | 9,059 | 5,320 | 1,601 |
Free Cash Flow Per Share | 231.09 | 49.20 | 201.57 | 118.38 | 35.62 |
Dividend Per Share | - | 125.000 | 140.000 | 130.000 | 25.000 |
Dividend Growth | - | -10.71% | 7.69% | 420.00% | -78.26% |
Gross Margin | 41.46% | 37.62% | 42.70% | 44.93% | 43.45% |
Operating Margin | 15.16% | 11.09% | 17.72% | 16.48% | 15.85% |
Profit Margin | 11.95% | 10.38% | 14.50% | 14.75% | 13.63% |
Free Cash Flow Margin | 18.00% | 4.04% | 17.74% | 10.35% | 3.38% |
EBITDA | 9,687 | 6,429 | 9,434 | 8,861 | 7,901 |
EBITDA Margin | 16.79% | 11.75% | 18.48% | 17.24% | 16.69% |
D&A For EBITDA | 940 | 362 | 387 | 391 | 398 |
EBIT | 8,747 | 6,067 | 9,047 | 8,470 | 7,503 |
EBIT Margin | 15.16% | 11.09% | 17.72% | 16.48% | 15.85% |
Effective Tax Rate | 19.38% | 19.71% | 21.34% | 23.42% | 23.79% |
Revenue as Reported | 57,700 | 55,931 | 51,842 | 52,036 | 47,890 |
Advertising Expenses | - | 2,927 | 2,412 | 3,153 | 3,080 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.